Heart disease prevention is becoming more personalized and precise. Doctors have traditionally relied on a standard cholesterol test, but that alone doesn’t give the full picture of someone’s risk for clogged arteries. New guidelines now encourage looking beyond just “bad cholesterol” (LDL). They include better risk calculators, pay more attention to other important particles in the blood, bring back specific cholesterol targets, and use heart scans (like calcium scoring) to get a clearer view of artery health.
In simple terms, instead of judging heart risk by just one cholesterol number, it’s better to think about it in three ways: how many harmful particles are in the blood, how much inflammation is affecting the blood vessels, and what imaging shows about actual plaque buildup in the arteries.
If I had to choose the core advanced markers every prevention-minded practice should prioritize, they would be these four:
A regular cholesterol test tells you how much cholesterol is in your blood. An NMR test goes a step further and shows how many cholesterol particles you have and what size they are.
This matters because sometimes your cholesterol number can look “normal,” but you still have a high number of harmful particles that can clog arteries. This is especially common in people with insulin resistance, diabetes, or high triglycerides.
ApoB (below) is usually the simplest way to measure this, but NMR testing can give extra detail when things aren’t clear.
ApoB is one of the most useful modern tests for heart risk.
Think of it this way: every harmful cholesterol particle has one ApoB “tag,” so measuring ApoB tells you how many artery-clogging particles are in your blood.
Even if your LDL (“bad cholesterol”) looks fine, a high ApoB means you may still be at risk. This is especially important if you have diabetes, high triglycerides, or lingering risk despite “good” cholesterol numbers.
Lp(a) is now considered a major risk factor for heart disease.
It’s mostly determined by your genes and doesn’t change much with diet or lifestyle. Because of that, experts now recommend checking it at least once in your life.
If your Lp(a) is high, it means you may need to be more aggressive about controlling other risk factors (like LDL cholesterol, blood pressure, etc.).
hsCRP is a simple blood test that measures inflammation in your body.
It doesn’t directly measure plaque, but it helps identify hidden inflammation in your blood vessels — which can increase heart disease risk, even if your cholesterol looks okay.
In short, it helps catch risk that standard cholesterol tests might miss.
These can be useful in certain situations but aren’t usually the first tests doctors rely on:
This looks at HDL (“good cholesterol”) function. It can give extra detail, but it’s not as important for risk prediction as ApoB or Lp(a).
Higher levels can be linked to heart risk, vitamin deficiencies (like B vitamins), or kidney issues. It’s more useful when there’s a specific concern rather than for routine screening.
This is tied to inflammation in artery plaque. It can give insight into plaque activity.
This marker reflects oxidative stress (damage in the body). It can be helpful in higher-risk or complex cases.
This is related to gut bacteria and how your body processes certain foods. It’s still an emerging marker, meaning it’s interesting but not yet a routine part of care.
This marker is linked to blood vessel function. Like some of the others above, it may provide extra insight but isn’t part of standard heart risk testing yet.
Instead of just asking “Is my cholesterol high?”, modern heart risk assessment asks:
Both are useful — they just answer different questions.
A CAC scan is one of the most useful heart scans available today. It looks for calcium buildup in your heart arteries, which is a sign of plaque.
Key idea:
This test doesn’t replace bloodwork, it adds clarity.
Think of it like this:
Doctors often use CAC when they’re unsure how aggressive treatment should be.
Cleerly isn’t a new scan — it’s advanced software that analyzes a heart CT scan in much more detail.
Instead of just showing calcium, it can:
Simple way to think about it:
It’s more advanced and personalized, but not something everyone needs.
CIMT is an ultrasound of the neck arteries that looks at artery thickness or plaque.
In plain terms:
It’s not the go-to test anymore, but it can still provide useful clues in some cases.
The new 2026 ACC/AHA multisociety dyslipidemia guideline marks a real shift in preventive cardiology:
That is exactly why advanced marker testing matters. We are moving from a cholesterol-only model to a particle + inflammation + plaque model.
For most adults serious about prevention, the minimum advanced cardiovascular workup should include:
Nonnegotiable:
Useful in selected patients:
The future of heart disease prevention isn’t just asking:
“What’s your LDL (bad cholesterol)?”
It’s asking:
At Nurture MD, we believe cardiovascular care should be proactive, personalized, and rooted in the most current science. As guidelines evolve and our understanding of risk deepens, we remain committed to staying at the forefront—integrating advanced testing, thoughtful interpretation, and individualized care plans to help you take control of your long-term health.
Prevention isn’t one-size-fits-all. It’s about understanding your unique biology, identifying risk early, and creating a strategy that supports you for years to come.
If you’re interested in a more comprehensive, personalized approach to cardiovascular health, we invite you to connect with us.
We look forward to supporting you on your journey to better health.
